Peter Crook

424 total citations
10 papers, 141 citations indexed

About

Peter Crook is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Peter Crook has authored 10 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Peter Crook's work include COVID-19 Clinical Research Studies (4 papers), Antibiotic Use and Resistance (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Peter Crook is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Antibiotic Use and Resistance (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Peter Crook collaborates with scholars based in United Kingdom and Rwanda. Peter Crook's co-authors include Paul Middleton, Sujit Mukherjee, Roberta Forlano, Mark Thursz, R. Judge, Anna Daunt, Pablo N. Perez‐Guzman, Shevanthi Nayagam, Timothy B. Hallett and Katharina Hauck and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and QJM.

In The Last Decade

Peter Crook

9 papers receiving 139 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Crook United Kingdom 4 95 55 36 27 24 10 141
Peter Puplampu Ghana 11 143 1.5× 75 1.4× 19 0.5× 34 1.3× 26 1.1× 41 267
Francesc Barbosa Spain 9 89 0.9× 58 1.1× 13 0.4× 22 0.8× 9 0.4× 19 207
Christopher H Pham United States 8 47 0.5× 115 2.1× 18 0.5× 27 1.0× 17 0.7× 25 241
Alexander Sarnowski United Kingdom 7 56 0.6× 60 1.1× 16 0.4× 40 1.5× 18 0.8× 13 215
Eliel Nham South Korea 8 107 1.1× 49 0.9× 20 0.6× 17 0.6× 30 1.3× 38 200
Davide Minisci Italy 9 257 2.7× 71 1.3× 33 0.9× 10 0.4× 55 2.3× 18 326
Daniel R. Drozd United States 9 92 1.0× 53 1.0× 21 0.6× 67 2.5× 8 0.3× 19 248
Sara Ombelet Belgium 5 48 0.5× 40 0.7× 42 1.2× 10 0.4× 38 1.6× 6 186
Carolina Rescigno Italy 6 65 0.7× 29 0.5× 18 0.5× 19 0.7× 17 0.7× 13 126
Richard Arndt United States 8 242 2.5× 50 0.9× 26 0.7× 17 0.6× 109 4.5× 17 351

Countries citing papers authored by Peter Crook

Since Specialization
Citations

This map shows the geographic impact of Peter Crook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Crook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Crook more than expected).

Fields of papers citing papers by Peter Crook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Crook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Crook. The network helps show where Peter Crook may publish in the future.

Co-authorship network of co-authors of Peter Crook

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Crook. A scholar is included among the top collaborators of Peter Crook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Crook. Peter Crook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crook, Peter, et al.. (2025). A case of ibrutinib-associated cryptococcal meningitis with a steroid-responsive immune reconstitution syndrome. Clinical Infection in Practice. 27. 100505–100505.
2.
Crook, Peter, et al.. (2024). The prevalence and clinical context of antimicrobial resistance amongst medical inpatients at a referral hospital in Rwanda: a cohort study. Antimicrobial Resistance and Infection Control. 13(1). 22–22. 3 indexed citations
3.
Crook, Peter, Clare Logan, Andrea Mazzella, et al.. (2023). The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study. BMC Infectious Diseases. 23(1). 808–808. 2 indexed citations
4.
Machin, Matthew, Peter Crook, Max Denning, et al.. (2021). Grass-roots junior doctor communication network in response to the COVID-19 pandemic: a service evaluation. BMJ Open Quality. 10(2). e001247–e001247. 3 indexed citations
5.
Crook, Peter. (2020). Cardiopulmonary resuscitation in the COVID-19 era – Will the risk-benefit shift in resource-poor settings?. Resuscitation. 151. 118–118. 6 indexed citations
6.
Forlano, Roberta, Benjamin H. Mullish, Sujit Mukherjee, et al.. (2020). In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. PLoS ONE. 15(10). e0240400–e0240400. 51 indexed citations
7.
Daunt, Anna, Sujit Mukherjee, Peter Crook, et al.. (2020). Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study. Spiral (Imperial College London). 13 indexed citations
8.
Perez‐Guzman, Pablo N., Anna Daunt, Sujit Mukherjee, et al.. (2020). Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study. Clinical Infectious Diseases. 73(11). e4047–e4057. 60 indexed citations
9.
Crook, Peter. (2000). Outbreak of S. typhimurium DT204b infection in Europe, 2000: update. Weekly releases (1997–2007). 4(51). 1 indexed citations
10.
Mutimer, David, et al.. (1990). Vasculitis in Primary Biliary Cirrhosis—Response to Prednisolone. QJM. 75(277). 509–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Puplampu Breakdown of academic impact, for papers by Francesc Barbosa Breakdown of academic impact, for papers by Christopher H Pham Breakdown of academic impact, for papers by Alexander Sarnowski Breakdown of academic impact, for papers by Eliel Nham Breakdown of academic impact, for papers by Davide Minisci Breakdown of academic impact, for papers by Daniel R. Drozd Breakdown of academic impact, for papers by Sara Ombelet Breakdown of academic impact, for papers by Carolina Rescigno Breakdown of academic impact, for papers by Richard Arndt
Rankless by CCL
2026